Locations:
SearchReflections on treating a patient with cognitive differences
The patient was unable to accept blood transfusions, and his cognitive differences prevented him from understanding the course of his leukemia as it progressed. Mikkael Sekeres, MD, MS, writes about what it was like to care for a patient with a loving family, limited treatment options and cognitive differences in the solitary times of COVID-19 in this New York Times column.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
“At the end, he didn’t suffer much. And as a parent, I can’t say for certain that I would have the strength to care for a dying child at home,” Dr. Sekeres writes. “But I also can’t be certain if it was right to preserve his hope until he passed, while leaving him unprepared for a solitary death; perhaps unaware of what was occurring, but perhaps aware.”
Dr. Sekeres is Director of Cleveland Clinic Cancer Center’s Leukemia Program. You can follow him on Twitter @MikkaelSekeres.
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients